382 reports of this reaction
3.0% of all LORATADINE AND PSEUDOEPHEDRINE SULFATE reports
#4 most reported adverse reaction
PRODUCT USE ISSUE is the #4 most commonly reported adverse reaction for LORATADINE AND PSEUDOEPHEDRINE SULFATE, manufactured by Bayer HealthCare LLC.. There are 382 FDA adverse event reports linking LORATADINE AND PSEUDOEPHEDRINE SULFATE to PRODUCT USE ISSUE. This represents approximately 3.0% of all 12,600 adverse event reports for this drug.
Patients taking LORATADINE AND PSEUDOEPHEDRINE SULFATE who experience product use issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT USE ISSUE is a less commonly reported adverse event for LORATADINE AND PSEUDOEPHEDRINE SULFATE, but still significant enough to appear in the safety profile.
In addition to product use issue, the following adverse reactions have been reported for LORATADINE AND PSEUDOEPHEDRINE SULFATE:
The following drugs have also been linked to product use issue in FDA adverse event reports:
PRODUCT USE ISSUE has been reported as an adverse event in 382 FDA reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT USE ISSUE accounts for approximately 3.0% of all adverse event reports for LORATADINE AND PSEUDOEPHEDRINE SULFATE, making it a notable side effect.
If you experience product use issue while taking LORATADINE AND PSEUDOEPHEDRINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.